NL-OMON25966招募中不适用
Pilot study to investigate whether oral phosphorus binders can reduce FGF23 levels and can influence vascular function as measured by pulse wave velocity in patiens with chronic kidney disease stage 3 (eGFR 30-60 ml/min/1,73 m2).
Vrije Universiteit Medisch Centrum (VUmc) Amsterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with eGFR 30-60 ml/min/1,73 m2;
- •2. Serum phosphorus level <1,49 mmol/L and >1,0 mmol/L;
排除标准
- •1. Known allergy or intolerance for sevelamer-containing drugs;
- •2. Patients with heart failure;
研究者
相似试验
尚未招募
不适用
Pilot study to investigate whether oral phosphorus binders can reduce FGF23 levels and can influence vascular function as measured by pulse wave velocity in patiens with chronic kidney disease stage 3 (eGFR 30-60 ml/min/1,73 m2).CKD10029149chronic kidney diseaserenal failureNL-OMON36731Vrije Universiteit Medisch Centrum20
已完成
2 期
Apremilast for Atopic Dermatitis - A Pilot Study in AdultsAtopic DermatitisNCT01393158Oregon Health and Science University16
已完成
2 期
The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU PatientsAcute HypophosphatemiaNCT06651892Ain Shams University42
招募中
Unknown
A clinical study to evaluate the effect of oral appliance on sleep apnea syndromeobstractive sleep apneaJPRN-UMIN000049236Tohoku University Graduate School of Dentistry45
进行中（未招募）
不适用
Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature. Study PRENECAincidence of nephrocalcinosis in extremely preterm infantsMedDRA version: 14.1Level: PTClassification code 10029146Term: NephrocalcinosisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2012-000298-22-ESFundació Clínic per a la Recerca Biomèdica